Károly Tóth
Impact in
Papers in
- Co-authors
- William S.M. Wold (53 shared papers)Ann E. Tollefson (43 shared papers)Konstantin Doronin (18 shared papers)Jacqueline F. Spencer (31 shared papers)Youcef M. Rustum (32 shared papers)Mohan N. Kuppuswamy (13 shared papers)Drew L. Lichtenstein (10 shared papers)Debanjan Dhar (9 shared papers)
- Journals
- Cancer Gene Therapy (9 papers)Journal of Virology (6 papers)Antiviral Research (6 papers)Molecular Therapy (5 papers)Virology (4 papers)
- Partner nations
- United StatesHungarySpain
In The Last Decade
Károly Tóth
168 papers receiving 5.2k citations
Károly Tóth's Hit Papers
Peers
Comparison fields: 5 of 129
- Genetics 2.4k
- Oncology 1.6k
- Infectious Diseases 780
- Biotechnology 322
- Molecular Biology 2.4k
Countries citing papers authored by Károly Tóth
This map shows the geographic impact of Károly Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Károly Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Károly Tóth more than expected).
Fields of papers citing papers by Károly Tóth
This network shows the impact of papers produced by Károly Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Károly Tóth. The network helps show where Károly Tóth may publish in the future.
Co-authors
The 25 scholars most cited alongside Károly Tóth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy Hit paper breakdown → | 2014 | 452 |
| 2 | 2000 | 179 | |
| 3 | 1998 | 178 | |
| 4 | 2012 | 173 | |
| 5 | 1999 | 163 | |
| 6 | 2004 | 155 | |
| 7 | 1997 | 147 | |
| 8 | 2006 | 144 | |
| 9 | 2008 | 125 | |
| 10 | 2014 | 106 | |
| 11 | 2008 | 105 | |
| 12 | MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. | 1996 | 104 |
| 13 | 2003 | 104 | |
| 14 | 2001 | 103 | |
| 15 | 2001 | 90 | |
| 16 | 2013 | 89 | |
| 17 | 2004 | 80 | |
| 18 | 2008 | 79 | |
| 19 | 2014 | 69 | |
| 20 | 2022 | 66 |
About Károly Tóth
Károly Tóth is a scholar working on Genetics, Oncology, Water Science and Technology, Infectious Diseases and Molecular Biology, having authored 175 papers that have together received 5.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (59 papers), CAR-T cell therapy research (24 papers), Viral Infectious Diseases and Gene Expression in Insects (24 papers), Fluoride Effects and Removal (23 papers), Viral gastroenteritis research and epidemiology (17 papers), RNA Interference and Gene Delivery (13 papers), Cytomegalovirus and herpesvirus research (11 papers) and Dental Health and Care Utilization (10 papers). The work is most often cited by research in Genetics (2.4k citations), Oncology (1.6k citations), Infectious Diseases (780 citations), Biotechnology (322 citations) and Molecular Biology (2.4k citations). Károly Tóth has collaborated with scholars based in United States, Hungary and Spain. Frequent co-authors include William S.M. Wold, Ann E. Tollefson, Konstantin Doronin, Jacqueline F. Spencer, Youcef M. Rustum, Mohan N. Kuppuswamy, Drew L. Lichtenstein, Debanjan Dhar, Shousong Cao and Farukh A. Durrani. Their work appears in journals such as Cancer Gene Therapy, Journal of Virology, Antiviral Research, Molecular Therapy and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.